Conditions: Erythema Rosacea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 445
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of oxymetazoline hydrochloride (HCl) cream 1.0% (AGN-199201) once daily compared to vehicle for the treatment of persistent moderate to severe facial erythema associated with rosacea.

Detailed description:

Arms:
arm 1: Oxymetazoline HCL Cream 1.0% applied to the face once daily for 29 days. arm 2: Vehicle to Oxymetazoline HCL Cream applied to the face once daily for 29 days.

Interventions: intervention 1: Oxymetazoline HCL Cream 1.0% intervention 2: Vehicle to Oxymetazoline HCL Cream
Intervention descriptions: intervention 1: Oxymetazoline HCL Cream 1.0% (AGN-199201) applied to the face once daily for 29 days. intervention 2: Vehicle to Oxymetazoline HCL Cream (AGN-199201) applied to the face once daily for 29 days.

Protocol document: